Quantcast
Home > Quotes > PRQR

ProQR Therapeutics N.V. Ordinary Shares (PRQR) Quote & Summary Data

PRQR 
$8.27
*  
0.28
3.27%
Get PRQR Alerts
*Delayed - data as of Jul. 23, 2019  -  Find a broker to begin trading PRQR now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    PRQR After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 8.24 / $ 9.11
Today's High / Low
$ 8.57 / $ 8.23
Share Volume
116,101
50 Day Avg. Daily Volume
201,416
Previous Close
$ 8.55
52 Week High / Low
$ 24 / $ 6.40
Market Cap
321,633,019
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
116,101
50 Day Avg. Daily Volume:
201,416

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.27

Trading Range

The current last sale of $8.27 is 29.22% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 8.57 $ 24
 Low: $ 8.23 $ 6.40

Company Description (as filed with the SEC)

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases (sometimes called orphan diseases) such as Leber's congenital amaurosis 10, Usher syndrome type 2 and autosomal dominant retinitis pigmentosa. Based on our unique proprietary RNA platform technologies, we are growing our pipeline with patients and loved ones in mind. ProQR was founded in February 2012 by Daniel de Boer, Gerard Platenburg, the late Henri Termeer and Dinko Valerio. Mr. de Boer is a passionate and driven entrepreneur and an advocate for patients with severe genetic diseases. He has assembled an experienced team of successful biotech executives as co-founders, management team members and early investors. The team has extensive experience in the discovery and development of products in multiple therapeutic areas.  ... More ...  



Risk Grade

Where does PRQR fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.57
Open Date:
Jul. 23, 2019
Close Price:
$ 8.27
Close Date:
Jul. 23, 2019


Consensus Recommendation

Analyst Info